From this report 2 items were of further interest to me:
1.Total expenses for the quarter were $847K
R&D expenses[$338K] plus Patent Portfolio expenses[$81K}represent nearly 50% of all expenses.
2.Costs associated with the capital raising of $5.06 M totalled $324K which represents 6.4% of the monies raised.Investors who took part in the capital raising are still in the red despite the discounted shareprice offering.
Kens
- Forums
- ASX - By Stock
- AVE
- Ann: March 2021 Quarterly Activities Report & Appendix 4C
Ann: March 2021 Quarterly Activities Report & Appendix 4C, page-5
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
34 | 92432246 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 20308827 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
34 | 92432246 | 0.003 |
22 | 67435176 | 0.002 |
10 | 14500009 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 20308827 | 11 |
0.005 | 56951736 | 28 |
0.006 | 23195872 | 17 |
0.007 | 15212721 | 9 |
0.008 | 5858888 | 5 |
Last trade - 10.00am 07/05/2024 (20 minute delay) ? |
|
|||||
Last
0.4¢ |
  |
Change
0.000 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
0.4¢ | 0.4¢ | 0.4¢ | 500000 | ||
Last updated 11.28am 07/05/2024 ? |
Featured News
AVE (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online